RecruitingNot ApplicableNCT05754593

Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis (MS), Compared to a Control Group

Study of Ovarian Reserve Concerning Patients With Multiple Sclerosis, Compared to a Control Group


Sponsor

University Hospital, Bordeaux

Enrollment

160 participants

Start Date

Dec 4, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The investigators want to evaluate ovarian reserve concerning patients with multiple sclerosis, compared to a control group of healthy women. This study will include women from 25 to 35 years old.


Eligibility

Sex: FEMALEMin Age: 25 YearsMax Age: 35 Years

Plain Language Summary

Simplified for easier understanding

This study is comparing ovarian reserve (egg supply) in women with multiple sclerosis (MS) versus women without MS, to understand whether the disease or its treatments affect fertility potential. **You may be eligible if...** - You are a woman between 25 and 35 years old - You are able to have children (reproductive age) - If you have MS: you have been diagnosed based on the McDonald 2017 criteria - You speak French without comprehension difficulties - You are covered by health insurance **You may NOT be eligible if...** - You have had ovarian surgery (such as cyst removal or removal of an ovary) - You have Turner syndrome or a fragile X genetic condition - You have endometriosis with significant ovarian damage Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALAnti-Mullerian hormone (AMH) level

Measure of Anti-Mullerian hormone (AMH) level by blood sample

OTHERAntral follicle count (AFC)

Measure of Antral follicle count (AFC) by ultrasound imaging

OTHERClinical assessment

MS history and MS treatments and Expanded Disability Status Scale (EDSS) score will be recorded


Locations(1)

CHU de Bordeaux - service de neurologie

Bordeaux, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05754593


Related Trials